

























Exploring Kinase Cosubstrate Promiscuity: Monitoring Kinase Activity 
through Dansylation 
 




Peptide synthesis.  Peptides were synthesized via standard solid phase synthesis using F-
moc chemistry, as described previously.[1]  To label the amino-terminus of peptide 5 with 
ROX for the FRET assay, the ROX fluorophore (0.45 mmol, Fluka) was coupled as described 
for each amino acid using HOBT (0.9 mmol, Acros), N,N’-diisopropylcarbodiimide (0.60 mmol, 
Acros) in DMF (5 resin volumes).  The resin was then washed with DMF (10 x with 10 resin 
volumes), CH2Cl2 (3 x with 10 resin volumes), CH2Cl2: ether (1:1) (3 x with 10 resin volumes), 
and ether (3 x with 10 resin volumes) in preparation for resin cleavage or storage, as de-
scribed previously.[1]  All peptides are purified using a reverse-phase C18 Altima column (250 
x 10mm, 5 µM particle, 300 Å) on a Varian(prep star) HPLC system, as described.[1] 
Dansylation of peptides. All reactions were performed as previously described.[2] Each re-
action contained either 200 units of PKA (New England Biolabs), 40 units of Abl kinase (New 
England Biolabs), or 40 units of CK2 (New England Biolabs).  Either 37.5 µM of PKA sub-
strate peptide 3, 15.0 µM of CK2 substrate peptide 4 (Promega), or 15.0 µM of Abl peptide 
substrate 5 (New England Biolabs) were also used.  To create a phosphorylated peptide, 2 
mM ATP was used.  To create a dansylated phosphopeptide, 2 mM ATP-dansyl (Adenosine 
5'-triphosphate [g]-N-(Dimethylaminonaphthalenesulfonyl)-1,5-pentanediamine from Affinity 
Labeling Technologies Inc) was used after evaporation of the methanol storage solvent.  All 
reactions were performed in a 10 µL total volume with the manufacturers specified kinase 
buffer and were incubated at 30°C for 2 h.  In the case of the reactions with CK2, better 
yields were obtained when a final concentration of 50 µM MgCl2 and 2% glycerol were added 
to the manufacturers recommended buffer.  To analyze the products of the reactions by 
MALDI-TOF MS, 1 µL of the crude reaction mixture was combined with 5 µL of matrix (α-
cyano-4-hydroxy cinnamic acid saturated in 70% acetonitrile, 30% water and 0.1% TFA), 
evaporated on a MALDI plate, and analyzed using a Bruker Ultraflex MALDI-TOF mass 
spectrometer. 
Quantitative mass spectrometric analysis. Dansylated phosphopeptides (produced with 
ATP-dansyl) and phosphorylated peptides (produced from ATP) were generated as de-
scribed above.  Each peptide was incubated in a solution of 2 N acetyl chloride in [D0]metha-
nol or [D4]methanol (200 µL, which produces anhydrous HCl in methanol or [D4]methanol) at 
24 °C for 2 h to afford methyl esterification, as described (Scheme S1).[2, 3]  Because the 
conditions of esterification were acidic, the phosphoramidate bond linking the dansyl label to 
the peptide was cleaved, creating the phosphopeptide required for quantitative mass spec-
trometric analysis.  For MALDI-TOF MS, the solvent was evaporated and equal quantities of 
the isotopically differentiated peptide samples were combined and prepared as described 
above (Figures S1-S3).   
 
Dansylation of β-casein. β-Casein (1.8 mM, Sigma) was combined with 80 units CK2 and 2 
mM of either ATP or ATP-dansyl, diluted to 10 µL with the manufacturer’s kinase reaction 
buffer supplemented with a final concentration of 50mM MgCl2 and 2% glycerol, and incubat-
ed for 2 h at 30 oC.  The reaction was diluted with an equal volume of 50 mM NH4HCO3 be-
fore heat denaturing at 90 oC for 60 seconds.  To afford complete proteolysis, 2.25 µg of se-
quencing grade trypsin (Promega) was incubated with the protein at 37 oC overnight.  The 
solvent was removed and the peptide fragments were subjected to acidic esterification and 
quantitative MS analysis as described above (Figure S4).   
Enzyme coupled kinetics analysis. Kinetics were assessed using a previously reported 
assay[4, 5] that monitors NADH absorbance at 360 nm after a series of enzyme coupled reac-
tions initiated by production of the ADP byproduct of the kinase reaction.  To test if the ATP 
analogues would interfere with the enzyme coupled assay, we tested the kinetics system 
with ADP in the presence of the desired ATP derivative.  Briefly pyruvate kinase (PK), lactic 

































































Scheme S1: Schematic representation of quantitative mass analysis. 
ADP (125 µM) and ATP derivative (250 µM for ATP-dansyl and 1mM for ATP or ATP-γS) were 
added to a pre-incubated solution of 30 units/mL lactic LDH, 12 units/mL PK, 1 mM PEP, 
0.128 mM NADH, 0.5 mg/mL bovine serum albumin, 50 mM HEPES (pH 7.5), 150 mM NaCl, 
10 mM KCl, and 10 mM MgCl2 in a total volume of 25 µL.  There was no significant change in 
rate from experiments containing only ADP and those with the addition of ATP analogue.  It 
is important to note that to avoid a significant rate decrease, ATP analogue should be added 
after the pre-incubation period. 
Kinase kinetic experiments were typically performed using the above conditions with 
the exclusion of ADP and preequilibrated with 1.29 mM of kemptide (LRRASLG).  5-250 µM 
ATP-dansyl was used, while 5 µM- 2 mM of ATP or ATP-γS was used.  We note that a maxi-
mum of 250 µM ATP-dansyl was used to avoid significant absorbance by dansyl at 360 nm.  
PKA (240 units, 12.63 nM, 0.48 µg/mL) was added to commence the reaction in a 100 µL 
total volume.  In the case with Abl, 40 units of Abl (2.73 nM, 0.31 µg/mL) were used in a total 
volume of 25 µL with 1.25 mM peptide 5, with all other components used at the same final 
concentrations.  Absorbance at 360 nm was taken every minute for 20 min on a GENios Plus 
Fluorimeter (Tecan).  Km and Vmax were calculated using a Lineweaver-Burke plot.[6]  The kcat 
value was then calculated by dividing the Vmax by the concentration of enzyme in appropriate 
units.   
FRET assay. We chose ROX as the FRET donor in these experiments due to the apprecia-
ble overlap between the emission of dansyl and excitation of ROX, and the minimal overlap 
of the dansyl and ROX emission wavelengths. In addition, rhodamine derivatives have been 
coupled with dansyl previously in FRET assays.[7, 8] ATP or ATP-dansyl (0.6 mM), ROX 5 
peptide substrate (0.1 mM) and Abl kinase (200 units) were combined, in the manufacturer 
kinase buffer, and incubated at 30 °C for 2 h.  Typical reaction volumes were 10 µL.  The re-
actions were diluted to 75 µL with water, transferred to a 384-well plate, and the fluorescence 
signal due to FRET emission at 595 nm was observed after excitation at 360 nm using a 
GENios Plus Fluorimeter (Tecan). The data are shown in Table S1 and Figure S7.  To verify 
that changes in lipophilicity and viscosity have no effect on ATP-dansyl fluorescence, we 
tested the environmental sensitivity of dansyl by comparing the fluorescence of ATP-dansyl 
alone to the fluorescence of ATP-dansyl in the presence of Abl or 10% glycerol.  In all cases, 
fluorescence intensity at 595 nm was equivalent. 
For the reactions containing mammalian cell lysates, 3 X 108 HeLa cells obtained 
from the National Cell Culture Center (www.nccc.com) were lysed in 3 mL of lysis buffer (50 
mM Tris pH 8, 150mM NaCl, 10% Glycerol, 0.5% Triton X-100) containing protease inhibitor 
cocktail V (1X- Calbiochem) by rotation at 4oC for 10 minutes. The cell debris was collected 
at 12 000 rpm and the supernatant (6 mg/mL of total protein content) was filtered through an 
EconoPak 10DG desalting column (BioRad), which likely removes endogenous ATP.  We 
note that unfiltered lysates were also compatible with the kinase-catalyzed dansylation reac-
tion (data not shown), consistent with our previous work.[2]  The lysates were stored at 4 oC 
until use in subsequent phosphorylation reactions.  The use of cell lysates a 384-well plate 
format was unfeasible because the low volume required in this format (6 µL) did not contain 
enough active, endogenous kinase activity for the reaction to produce signal.  As an alterna-
tive, a 96-well plate format was used.  Here, ATP or ATP-dansyl (1 mM), peptide (35 µM) and 
Abl kinase (200 units) were combined in the manufacturer kinase buffer using a typical reac-
tion volume of 50 µL.  For the FRET assays containing lysates, the reactions were performed 
as described except no kinase was added and lysates (32 µL) were used in the place of buf-
fer to obtain the 50 µL total reaction volume.  Reactions were also performed with unfiltered 
lysates to determine the activity with competitive ATP.  Results were identical to those with 
filtered lysates. 
FRET inhibition assay. Conditions identical to the FRET assay were used.  In reactions uti-
lizing inhibitors, a solution of inhibitor in 10% DSMO in water was incubated with the enzyme 
for at least ten minutes prior to addition to the remaining reaction components.  A final con-
centration of 30 µM staurosporine (MP Biomedicals), 30 µM DRB (5,6-Dichloro-1-ß-D-ribo-
furanosylbenzimidazole; Sigma), or 1 mM Imatinib (STI-571; Toronto Research Chemicals) 
was used. 
FRET kinetics analysis.  Abl (40 units, 6.83 nM, 0.12 µg/mL) and ROX 5 peptide substrate 
(1.25 mM) were incubated with 5-250 µM ATP-dansyl in provided manufacturers buffer in a 
384-well plate format. Reactions were performed in a 25 µL volume.  Measurements of FRET 
were taken every two minutes for 30 min on a GENios Plus Fluorimeter (Tecan), using an 
excitation wavelength of 360 nm and an emission of 595 nm.  To convert fluorescence inten-
sity into micromolar values, the following, previously published,[9] equation was used:  
 
 
where P(t) is the concentration of product, I(t) the fluorescent signal, fs the fluorescence per 
µmol of starting material, S0 the original concentration of starting material, and fp the fluores-
cence per µmol of product.  The fluorescence constants (fs and fp) for the starting material 
and product were obtained by plotting fluorescence intensity versus concentration of com-
pound and using the slope of the resulting line. The slopes were 3892.3 FU/µmol for ATP-
dansyl (fs) and 5880.9 FU/µmol for peptide 6 (fp). Km and Vmax were calculated using a Line-
weaver-Burke plot (Figure S6 and S7).[6] The kcat was then calculated by dividing the Vmax by 
the concentration of enzyme in appropriate units.   
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0.40 ± 0.10  0.73 ± 0.07 1.0 ± 0 1.30 ± 0.05  
 
1.03 ± 0.05  
 
1.01 ± 0.02  
 
1.31 ± 0.03  
 
aNormalized fluorescence values were calculated by dividing the fluorescence intensities of each reaction by the intensity of the reaction with ROX 5 and ATP-dansyl 
but without Abl kinase (Column 1), with the baseline set to 1.0.  The average and standard error are shown from three independent trials.  bThe background signal is 
due to emission of ATP-dansyl; ATP-dansyl alone gave equivalent fluorescence signal.  cColumn number corresponds to the column in Figure 2B. 

















Column 8 [b] 
Normalized  
Fluorescence 
1.0 ± 0 1.32 ± 0.02  
 
1.06 ± 0.02  
 
aNormalized fluorescence values were calculated by dividing the fluorescence intensities of each 
reaction to the intensity of the reaction with ROX 5 and ATP-dansyl but without HeLa cell lysates 
(Column 6), with the baseline set to 1.0. The average and standard error are shown from at least 
















Figure S1:  Quantitative MALDI analysis of PKA substrate (3) with PKA and ATP-dansyl (1c).  The 
peak at 1152.565 m/z corresponds to methylated phosphopeptide after phosphorylation with ATP -
dansyl and acidic dansyl cleavage, while the peak at 1155.595 m/z corresponds to deuterated, meth-















Figure S2:  Quantitative MALDI analysis of CK2 peptide (4) with CK2 and ATP-dansyl (1c).  The peak 
at 1540.567 m/z corresponds to the hepta-methylated phosphopeptide after phosphorylation with 
ATP-dansyl and acidic dansyl cleavage, while the peak at 1561.713 m/z corresponds to the deuterat-
ed, hepta-methylated phosphopeptide due to ATP phosphorylation.  The conversion of this single ex-













Figure S3: Quantitative MALDI analysis of Abl peptide (5) reaction with Abl and ATP -dansyl (1c).  The 
peak at 1442.915 m/z corresponds to the dimethylated phosphopeptide due to phosphorylation by 
ATP-dansyl and acidic dansyl cleavage, while the peak at 1448.960 m/z corresponds to the 
phosphopeptide due to deuterated, dimethylated ATP phosphorylation.  The conversion of this single 



















Figure S4: Quantitative MALDI analysis of trypsin digested β-casein after reaction with CK2 and either 
ATP (1a) or ATP-dansyl (1c).  The peaks at 2237.770 and 2223.787 m/z correspond to heptamethylat-
ed and hexamethylated phosphopeptides, respectively, due to partial methyl esterification of the acid-
cleaved, ATP -dansyl phosphorylated sample.  The peaks at 2260.015 and 2241.873 m/z correspond 
to the deuterated hexamethylated and heptamethylated phosphopeptide, respectively, due to partial 
methyl esterification of the after ATP phosphorylated sample.  The percentage conversion was deter-
mined by comparing the areas under both sets of peaks. The peak at 2252.811 m/z represents a 















































Figure S5: Lineweaver-Burke plots of ATP and derivatives with PKA and kemptide substrate 
(LRRASLG) obtained with the enzyme-coupled assay for kinase activity.  Each plot is a single 
representative of at least three independent trials.  The kcat was then calculated by dividing the 
Vmax  by the concentration of enzyme in appropriate units.   
 
 
Km = 24.0 µM 
Vmax = 46.9 nM/s 
Km = 272 µM 
















Km = 19.9 µM 





















































Figure S6: Lineweaver-Burke plots of ATP and derivatives with Abl and peptide substrate (EAIY-
AAPFAKKK) using data obtained with the enzyme-coupled assay for kinase activity (A and B) or 
the FRET-based assay (C).  Each plot is a single representative of at least three independent 
trials.  The kcat was then calculated by dividing the Vmax by the concentration of enzyme in appro-
priate units. 
Km = 125 µM 
Vmax  = 2.68 nM/s 
Km = 48.1 µM 
Vmax  = 22.4 nMl/s 
A) 
Km = 46.1 µM 
































Figure S7: Full spectra of FRET assay without kinase (blue) and with kinase (pink) observed between 
400 and 625 nm.  Reactions were performed in 96-well format discussed above with measurements 
taken on an Aviv Automated Titrating Differential/Ratio Spectrofluorimeter ATF 105.  A 25% increase 
in fluorescence at 600 nm was observed in the presence of kinase in this single trial.   
 
